26 May 2011 0 Comments

Blogging about Biologists

I’ve had the good fortune to interview each of the scientists below.  I’ve learned about their research, their labs, and how each one got started in science.  Now I want more!
If you are interested in us highlighting your research in Sigma BioBlogs, please get in touch with me via Twitter at Twitter.com/kristy3m or by email at kristy.meyer<at> sial <dot> com, and we will talk about making your story a part of Sigma BioBlogs.

Thanks to all of our interview subjects!  It’s an honor to get to know you better.

    Share and Enjoy:
    • services sprite Blogging about Biologists
    • services sprite Blogging about Biologists
    • services sprite Blogging about Biologists
    • services sprite Blogging about Biologists
    Tags:
    19 May 2011 0 Comments

    Phosphorylation is the focus: Interview with Chris Dieni, PhD

    Chris Dieni is an interesting researcher, in that he’s studying the mechanisms by which phosphorylation occurs.  Since we have a new Kinase and Phosphatase Biology Product Guide, we thought it was a perfect time to bend his ear about the ways that he investigates phosphorylation.

    Chris Micro crop Phosphorylation is the focus: Interview with Chris Dieni, PhD

    Chris Dieni, PhD, and his no-name microscope.

    What area of phosphorylation research is your focus?

    My background is in comparative biochemistry and physiology, with an emphasis on the molecular mechanisms involved in the adaptation to stress. I’ve looked at frogs that freeze solid and ground squirrels that hibernate over the winter, along with cancer cells that continue to grow and proliferate in deficient media. I look at enzymes that catalyze key (suspected) reactions in their survival, and whether these enzymes are regulated by post-translational modification to make them more or less active. Since phosphorylation is the most common PTM, that’s what I’ve studied.

    How do you perform Kinase Assays?

    Typically I rely on radioisotopes to run kinase assays, namely gamma-32P-ATP. I’ll use the ATP, a kinase- either commercial, purified from a homogenate/cell lysate, or in crude condition- and a target for that kinase like a peptide or whole protein. After the reaction is over, what I do next depends on whether I used a peptide or protein. If it’s a peptide, then it involves spotting on phosphocellulose (P81) paper, along with washes in phosphoric acid. If I used a protein as the target, I’ll boil with SDS-PAGE sample buffer, load into an acrylamide gel and run SDS-PAGE. Finally, the paper or gel is then exposed to a phosphor storage screen and scanned with a laser scanner/phosphorimager.

    Have you been able to move away from doing radioactive kinase assays?

    Sir Philip Cohen once referred to radioactive kinase assays as the “gold standard” and so it’s very, very difficult to move away from them. The thing about radioisotopes is that the methods for detecting them are very sensitive, so you can detect low levels of phosphorylation. Also, you can detect a hot phosphate no matter where it’ll turn up in a protein. That’ll become relevant and important in a minute.

    I’ve used another method with some success- in fact it was my first publication. It involved a peptide substrate for kinases that have a conjugated fluorophore. When the peptide is phosphorylated, magnesium ions are chelated by the phosphate and fluorophore, enhancing the fluorescence. The reaction can be detected in real-time, kinetically, using a fluorometer microplate reader.

    What I’ve also tried to do in the case of protein substrates and SDS-PAGE is, using nonradioactive ATP of course, use a phospho-specific stain, like the Pro-Q diamond phosphoprotein gel stain to see if any of the protein bands light up after reaction with a kinase. The problem with that is that it’s not very specific- only to the nanogram range, and so if you have very little phosphorylation going on, you’ll have a hard time detecting it.

    Finally, going further along that SDS-PAGE path, I’ve transferred proteins to a PVDF membrane and then probed with phospho-specific antibodies. The problem is, phospho-specific antibodies have limitations, so you can’t be too specific. If your antibody detects phosphorylation at serine-234 and instead, your protein is being phosphorylated- albeit beautifully- at threonine-658, your antibody won’t detect a speck and you’ll wrongfully assume that phosphorylation isn’t taking place. Antibodies of wider specificity won’t necessarily help because all antibodies out there rely, to some extent or another, on an epitope: not just a single amino acid of interest but a surrounding environment of amino acids, all of which an antibody binds to.

    If you’re interested in my comparing and contrasting of different methods, I’d like to remind you about a Bitesize Bio article I did awhile back.

    We understand that you have used some of our bioactive small molecules in the work that you’ve done. Can you tell us which ones and how you used them?

    I relied on high-quality Sigma biochemicals for stimulating (and inhibiting!) my endogenous signaling enzymes. I used compounds like phorbol myristate acetate (PMA) to stimulate protein kinase C activity; cyclic AMP and cyclic GMP to activate protein kinase A and protein kinase G, respectively; AMP to activate AMP-dependent protein kinase; calmodulin to activate calcium/calmodulin-dependent protein kinase, and so on.

    Some of the inhibitors included okadaic acid, to distinguish between protein phosphatise 1 and 2A, and cypermethrin to inhibit calcineurin or PP2C. In kinase assays using tissue extracts, protein kinase A is a very active kinase and can present a lot of interference, so we used protein kinase A inhibitors. The same was true for protein kinase G inhibitors.

    All of that doesn’t even begin to include the coupling enzymes and substrates that I used to assay enzymes after I had stimulated protein kinases or phosphatases. For instance, I would take a muscle extract, and stimulate protein kinases to try and phosphorylate the something like AMP deaminase within the muscle.  But then, what effect did that potential phosphorylation have on AMPD enzyme activity/kinetics? To find that out, I’d need to assay AMPD enzyme activity once again, which required Sigma products like AMP as the substrate for AMPD, and then the coupling reaction involving glutamate dehydrogenase, alpha-ketoglutarate, and NADH, so that I could detect it spectrophotometrically at 340 nm.

    Share and Enjoy:
    • services sprite Phosphorylation is the focus: Interview with Chris Dieni, PhD
    • services sprite Phosphorylation is the focus: Interview with Chris Dieni, PhD
    • services sprite Phosphorylation is the focus: Interview with Chris Dieni, PhD
    • services sprite Phosphorylation is the focus: Interview with Chris Dieni, PhD
    13 May 2011 0 Comments

    Scientists are entertaining – Part 2

    It’s time once again to shine the spotlight on interesting things that scientists do.  In our first installment, we looked at  humor and funny science related pages, groups and blogs created by scientists in social media.

    Today we look at  “The Secret Life of Scientists and Engineers” segments from the NOVA Series.  They profile the lives of scientists and also reveal a “secret” hobby or passion outside of the lab.

    One such scientist shares her home of St. Louis, MO with Sigma Life ScienceRachel Collins is a Microbiologist by day…and “Your Soul’s Tormentor” by night. She works culturing and studying microbes in the lab during her “Science Life” and then torments her wrestling opponents as MsChif.

    Dave Sulzer of Columbia University is another scientist with a “secret life”.  The Sulzer lab focuses on understanding the mechanisms that underlie diseases (Parkinson’s, schizophrenia, autism, and drug addiction) that occur in synapses in the cortex and basal ganglia.   His lab was the first to visualize quanta, the basic building block of neurotransmission. For his secret, he conducts an orchestra of elephants.  Pick up an elephant orchestra CD on Amazon.

    Do you have a secret life outside the lab?  Share with us in the comments, or by tweeting to #SecretSci.

    Share and Enjoy:
    • services sprite Scientists are entertaining   Part 2
    • services sprite Scientists are entertaining   Part 2
    • services sprite Scientists are entertaining   Part 2
    • services sprite Scientists are entertaining   Part 2
    5 May 2011 0 Comments

    Creating a multi-dimensional view of action in solid tumor cells

    PhilLorenzi Headshot1 240x300 Creating a multi dimensional view of action in solid tumor cells

    Phil Lorenzi focuses on an enzyme-drug called L-asparaginase

    We got a chance to interview Dr. Phil Lorenzi of the MD Anderson Cancer Center about the work that he does expanding the usage of L-asparaginase against solid tumors.

    What is the focus of your research?

    We focus on an enzyme-drug called L-asparaginase and a well-characterized panel of 60 cancer cell lines called the NCI-60.

    The drug, L-asparaginase, has been used since the 1960s to treat acute lymphoblastic leukemia by depleting the amino acids asparagine and glutamine, which leukemia cells cannot generate.

    In our work with the NCI-60 cell lines we’ve established rationale for testing L-asparaginase against solid tumors, which could greatly expand its utility by enabling treatment of different cancer types beyond acute lymphoblastic leukemia.

    We found a strong negative correlation between the anticancer activity of L-asparaginase and the expression of asparagine synthetase (ASNS; the endogenous enzyme that makes asparagine).

    With collaborators, our next goal is to confirm whether that correlation holds up in patients with solid tumors (trials are underway), thereby permitting a “personalized medicine” approach to therapy with L-asparaginase.

    We’re also looking for additional biomarkers of L-asparaginase activity by studying the drug’s mechanism of action.  To that end, our projects are multidisciplinary, spanning the fields of pharmacogenomics, systems biology, systems pharmacology, bioinformatics, metabolomics, proteomics, cellular biology, and molecular biology.  Since the drug works by depleting the amino acids asparagine and glutamine, our research has nutritional implications as well.

    So you are using multidisciplinary methods to assess the mechanism of action for L-asparaginase?

    Correct.  No single platform has all of the answers.  By integrating multiple molecular profiling data sets (e.g., protein expression and small molecule concentrations), we get a “multidimensional” view of what’s happening in cancer cells.  Years ago, my mentor (Dr. John N. Weinstein) coined the term “integromics” to describe the integration of molecular profiling data from different platforms.  That’s the foundation of our overall approach.

    How did you first get interested in science?  When did you know it would be your career?

    In 7th grade (age 12), my father helped me brainstorm ideas for a science fair project.  I ended up testing different metals (readily available materials from the local hardware store; nothing fancy) to see which ones yielded the best battery as measured by output to a small light bulb.  I actually hated that project…but looking back, it must have sparked my interest in science. .

    How did you choose Prestige antibodies®?** How do they fit into your research?

    We recently screened about 14 antibodies against ASNS from a variety of vendors, and we found the Prestige antibody to be the most specific and sensitive.  As we’ve adopted a “systems” approach to studying drug mechanisms of action, the number of genes/proteins we’re studying is growing quickly.  Sigma’s Antibody BioGuarantee Program greatly enhances the likelihood that we’ll find an antibody that works for each of those proteins.

    **Prestige Antibodies are powered by Atlas Antibodes

    Share and Enjoy:
    • services sprite Creating a multi dimensional view of action in solid tumor cells
    • services sprite Creating a multi dimensional view of action in solid tumor cells
    • services sprite Creating a multi dimensional view of action in solid tumor cells
    • services sprite Creating a multi dimensional view of action in solid tumor cells
    26 April 2011 0 Comments

    Seeking: RNAi users with opinions

    biosilencing rnai.Par .0001.Image .590.590 Seeking: RNAi users with opinions

    Our goal is to ensure we provide you with product and technology innovations that can advance your RNAi program.

    To learn more about your perspectives and experiences in using RNAi technologies,  we are conducting 30 minute scientific interviews with scientists who are RNAi users.

    These interviews will focus on your experiences in using RNA interference technologies…the good, the bad, and the ugly.

    We want users of all kinds of RNAi technologies to tell us what works, what doesn’t work, and what would make your life easier.

    Please email our RNAi marketing team at RNAiMarketing <at> sial.com to let us know you are interested in participating.

    Share and Enjoy:
    • services sprite Seeking: RNAi users with opinions
    • services sprite Seeking: RNAi users with opinions
    • services sprite Seeking: RNAi users with opinions
    • services sprite Seeking: RNAi users with opinions
    22 April 2011 0 Comments

    Tania Nolan, PhD: Single mom and RT-qPCR expert

    Don’t let go of those “impossible” dreams.  Tania Nolan, Ph. D., Global Manager Sigma Life Science, and leading expert on RT-qPCR, certainly doesn’t.

    Where her bio began

    Dr. Nolan had every intention of going into computer engineering with a focus on hardware, until the mid-1980’s.  While at home with her second baby, she turned on the TV and happened upon an hour-long program on DNA analysis.

    She was hooked.  She read every textbook she could find on molecular biology, and then enrolled in a “distance learning university” in her native England.  A year later she was enrolled as a full time student in biology/biochemistry at the University of Salford near Manchester—more convenient and better able to meet her needs as a single mother.

    Making the transition from computers to biology was not easy.  She recalls a plant biology class in which the professor referred to ‘xylem’.  Everyone else knew what he was talking about, but she was stymied trying to look up ‘zylem’ in the pre-Google world of text books.

    Becoming a world leader in RT-qPCRTania Nolan.qpcr a z Tania Nolan, PhD: Single mom and RT qPCR expert

    Of course, she graduated with honors, and enrolled in graduate school at the University of Manchester.  There is where she became interested in novel and better ways to analyze gene expression—first in the life cycle of the yeast C. albicans, which causes thrush and many other problems for immunocompromised patients, and then later in breast cancer as an AstraZeneca Postdoc Fellow.

    RT-qPCR is just her cup of tea. After Northern Blots and P32 labeling, being able to quantify mRNAs in real time is a real relief.

    Dr. Nolan is considered one of the world’s leading experts on RT-qPCR.  You might say she wrote the book—or at least major parts of the textbook “The A-Z of Quantitative PCR.”  In 2009 she became one of the prominent scientists who devised MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments.)  These guidelines, which aim to standardize qPCR techniques and ensure that published results conform to the same requirements, so that these experiments can be properly interpreted and repeated.  MIQE has become an accepted as a best practice instrument in molecular biology labs.

    Optimizing the assay is one of her main areas of expertise, and she travels the world for Sigma speaking about qPCR.  Besides the EU and America, she has been to Japan, Singapore, Maylasia, and South America.  Africa and the Middle East are on her ‘to go’ list.

    A passion for music

    Her travel kit includes two clarinets—one pitched in A and one in B flat.  After a few years of reading books during her travels, she decided to return to music.  She recalls with great pleasure returning to London at 10am with jet-lag after running a qPCR workshop in the USA so that she could attend a weekend workshop starting that evening with the great British clarinetist, David Campbell.Tania.Nolan .Clarinets german 114x300 Tania Nolan, PhD: Single mom and RT qPCR expert

    She wants to develop a music-based relaxation workshop, perhaps as a lunchtime activity for the workplace.  Making music develops teamwork, she says; she can envision pulling together a variety of instruments, even using non-trained individuals on drums and in other percussion roles.

    Rising to the challenge

    Having started her family before starting her career definitely shaped Tania Nolan’s life.  It made her determined to avoid the single parent poverty trap and do something significant with her life.  She continues to do research and writing projects, and is currently involved in getting some of her qPCR expertise on the web as short instruction videos.

    **This blog is brought to you by the new OligoArchitect™ Primer and Probe Design tool from Sigma Life Science.**

    Share and Enjoy:
    • services sprite Tania Nolan, PhD: Single mom and RT qPCR expert
    • services sprite Tania Nolan, PhD: Single mom and RT qPCR expert
    • services sprite Tania Nolan, PhD: Single mom and RT qPCR expert
    • services sprite Tania Nolan, PhD: Single mom and RT qPCR expert
    15 April 2011 0 Comments

    Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine

    Congratulations to Dr. Condie Carmack  of the Baylor College of Medicine on finding the Golden Bioactive Small Molecules Catalog at AACR 2011.   To win our first ever Twitter treasure hunt, he carefully followed clues on Twitter and tracked down the golden catalog awaiting him at the concierge’s desk at the Rosen Centre hotel in Orlando, Florida.

    Condie Carmac.BSM winner Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine

    Condie Carmack of Baylor College of Medicine wins!

    Dr. Carmack runs the Cancer Genetics Laboratory (CGL) at Baylor College Of Medicine.  The CGL is a clinical diagnostic lab, where Dr. Carmack’s team develops genetic tests related to clinical outcome.  The CGL provides gene sequencing testing, deletion/duplication testing, chromosome analysis, FISH testing, and chromosomal microarray analysis (CMA). CGL can provide cancer diagnostic testing services for both pediatric and adult cancer studies.

    When asked how he began his 30-year career in Molecular Biology, Dr. Carmack said that his father was a doctor.  So growing up in this environment helped to foster the interest he has had in applied biology for his entire life.

    Share and Enjoy:
    • services sprite Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine
    • services sprite Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine
    • services sprite Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine
    • services sprite Dr. Condie Carmack: Cancer Genetics Laboratory Baylor College of Medicine
    8 April 2011 0 Comments

    Learn about RNAi screening at Johns Hopkins University School of Medicine

    Register now for a special RNAi screening workshop at Johns Hopkins University School of Medicine: Technology Center for Networks and Pathways on April 26-28, 2011

    Bioeducate Linkdin image1 Learn about RNAi screening at Johns Hopkins University School of Medicine

    Biouniversity will be at Johns Hopkins for an RNAi screening workshop

    In this new course, you will learn the principles of setting up genome-wide RNAi screens using pooled lentiviral shRNA libraries. We will focus on the deconvolution step, which is critical to pooled library screening.   The workshop will conclude with in-depth sessions on data analysis, statistics, and interpretation.

    The following scientists will be speakers during the training:

    Dr. Jef Boeke, Johns Hopkins School of Medicine, HiT Center

    Dr. David Root, Broad Institute of MIT and Harvard

    Dr. William Hahn, Dana Farber Cancer Institute and Harvard Medical School

    Dr. Rafael Irizarry, Johns Hopkins Bloomberg School of Public Health

    Dr. Yu-yi Lin, National Taiwan University

    Register now!!

    Share and Enjoy:
    • services sprite Learn about RNAi screening at Johns Hopkins University School of Medicine
    • services sprite Learn about RNAi screening at Johns Hopkins University School of Medicine
    • services sprite Learn about RNAi screening at Johns Hopkins University School of Medicine
    • services sprite Learn about RNAi screening at Johns Hopkins University School of Medicine
    31 March 2011 0 Comments

    Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center

    In the most recent print edition of Biowire, we interviewed Dr. Hakim Djaballah at the Memorial Sloan-Kettering Cancer Center.

    His high throughput screening laboratory provides both chemical and RNAi screening services and is helping oncology clinicians and basic researchers to harness the power of high throughput screening technologies towards a better understanding of signaling pathways in cancer cells and discovering novel drugs to treat cancer.

    Dr. Djaballah 11 Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center

    Dr. Hakim Djaballah in the lab

    As a result they are developing new clinical strategies, and furthering the understanding of various types of cancer.

    Here is a sampling of Dr. Djaballah’s collaborative publications.

    Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.

    High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

    Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.

    Get the full list.

    We look forward to hearing more about the successes of the Dr. Djaballah and his collaborators!  Subscribe to Biowire to stay informed of news from Sigma Life Science and the researchers we serve.

    Share and Enjoy:
    • services sprite Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center
    • services sprite Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center
    • services sprite Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center
    • services sprite Dr. Hakim Djaballah of Memorial Sloan Kettering Cancer Center
    30 March 2011 0 Comments

    What are your tips for a successful conference?

    Throughout March and April, Sigma Life Science has teams  participating in several conferences:  Association of Biomolecular Resource Facilities Society for Laboratory Automation and ScreeningAmerican Association for Cancer Research (AACR)Experimental BiologySociety of Toxicology, and ADMET Europe.

    Do you have some tips and tricks for getting the most out of your conferences?

    We’d love to hear about about how you work the exhibit halls and vendor seminars, getting the most out of sessions,  and how you find and hear about your chosen hospitality events!

    Our scientists gave us some feedback focusing on how they make the most of the information that’s being presented and to network as much as possible:

    • You have to hang out socially at the bar or for dinner with other attendees after sessions.  You get a real feel for people’s opinions on trends in the sessions of the day.  Additionally, sometimes problems or themes not addressed in the public forum come up in discussion, that give you a better idea of the bigger picture.
    • Schedule follow up conversations (e.g. lunch, dinner or drinks) with speakers, poster presenter and PI’s who are presenting interesting technologies.
    • Follow the Twitter stream to keep up w/ sessions you can’t attend.
    • If you rely upon caffeine, you need to do some behavioral studies to determine line forming patterns, and the best way to obtain your Starbucks or other caffeinated beverages.

    We look forward to hearing about your meetings!!  Follow where we are at Twitter.com/YourFaveGene.

    Share and Enjoy:
    • services sprite What are your tips for a successful conference?
    • services sprite What are your tips for a successful conference?
    • services sprite What are your tips for a successful conference?
    • services sprite What are your tips for a successful conference?